Should CJ Corp Decouple Its Pharma Division?

CJ Corp is one of South Korea's conglomerates - or Chaebol - with operations in diverse fields such as food, entertainment, logistics and pharmaceuticals. The firm wants to become the leading research-based drugmaker in South Korea and has targeted biopharmaceuticals as a premier growth opportunity. BMI investigates whether the division should be decoupled from the parent

To read the full article, please choose one of the following options: